.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Chubb
Deloitte
AstraZeneca
Argus Health
US Department of Justice
Cipla
Julphar
Colorcon
Covington

Generated: June 26, 2017

DrugPatentWatch Database Preview

Sodium nitroprusside - Generic Drug Details

« Back to Dashboard

What are the generic sources for sodium nitroprusside and what is the scope of sodium nitroprusside patent protection?

Sodium nitroprusside
is the generic ingredient in four branded drugs marketed by Namigen Llc, Abraxis Pharm, Akorn, Roche, Abbvie, Abbott, Hospira, Teva Parenteral, Baxter Hlthcare, Exela Pharma Scs Llc, and Nexus Pharms, and is included in twelve NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are one thousand three hundred and seventy-nine drug master file entries for sodium nitroprusside. Six suppliers are listed for this compound.

Summary for Generic Name: sodium nitroprusside

Tradenames:4
Patents:1
Applicants:11
NDAs:12
Drug Master File Entries: see list1379
Suppliers / Packagers: see list6
Clinical Trials: see list2,361
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:sodium nitroprusside at DailyMed

Pharmacology for Ingredient: sodium nitroprusside

Drug ClassVasodilator
Physiological EffectVasodilation
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Exela Pharma Scs Llc
NIPRIDE RTU IN SODIUM CHLORIDE 0.9%
sodium nitroprusside
SOLUTION;IV (INFUSION)209387-001Mar 8, 2017RXYesYes► Subscribe► Subscribe
Akorn
SODIUM NITROPRUSSIDE
sodium nitroprusside
INJECTABLE;INJECTION208635-001May 4, 2017APRXNoNo► Subscribe► Subscribe
Namigen Llc
SODIUM NITROPRUSSIDE
sodium nitroprusside
INJECTABLE;INJECTION207426-001Dec 8, 2016APRXNoNo► Subscribe► Subscribe
Baxter Hlthcare
SODIUM NITROPRUSSIDE
sodium nitroprusside
INJECTABLE;INJECTION018581-001Jul 28, 1982DISCNYesNo► Subscribe► Subscribe
Abbott
NITROPRESS
sodium nitroprusside
INJECTABLE;INJECTION071555-001Nov 16, 1987DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Moodys
Covington
Cantor Fitzgerald
McKesson
Cipla
US Department of Justice
Baxter
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot